ProShares UltraShort NASDAQ Biotechnology
11 hedge funds and large institutions have $4.82M invested in ProShares UltraShort NASDAQ Biotechnology in 2017 Q4 according to their latest regulatory filings, with 4 funds opening new positions, 3 increasing their positions, 2 reducing their positions, and 3 closing their positions.
Holders
11
Holders Change
+1
Holders Change %
+10%
% of All Funds
0.25%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
4
Increased
3
Reduced
2
Closed
3
Calls
$599K
Puts
$772K
Net Calls
-$173K
Net Calls Change
-$621K
Top Buyers
Top Sellers
1 |
1
UBS Group
Zurich,
Switzerland
|
$11K |
2 |
2
Morgan Stanley
New York
|
$25K |
3 |
AG
3
Advisor Group
Phoenix,
Arizona
|
$0 |
4 |
![]()
4
Simplex Trading
Chicago,
Illinois
|
$0 |